John Mascarenhas, MD, Mount Sinai School of Medicine, discusses Imetelstat, Telomerase Inhibitor Myelofibrosis Intravenous drug given every 3-4 weeks at Imedex Great Debates 2018.
Imetelstat, Telomerase Inhibitor Myelofibrosis Intravenous drug given every 3-4 weeks
